MACQUARIE GROUP LTD
Position in ALNY — Alnylam Pharmaceuticals, Inc.
CIK 1418333
Sydney, NSW 2000, C3
Position in ALNY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,304,471
+$995,001 QoQ
Shares Held
20,943
+30.5% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#225
of 784 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 63%
Shared 37%
None 0%
Common Shares in ALNY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MACQUARIE GROUP LTD holds $47,158,112 across 21 Biotechnology names. ALNY ranks #3 (13.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
37,980 | $18,865,804 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
17,532 | $10,931,901 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
This page
|
20,943 | $6,304,471 | |
| 4 | INCY |
Incyte Corp
|
33,301 | $3,775,000 | |
| 5 | RPRX |
Royalty Pharma plc
|
41,037 | $2,300,944 | |
| 6 | EXEL |
Exelixis, Inc.
|
27,485 | $1,495,458 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
3,331 | $623,829 | |
| 8 | INSM |
INSMED Inc
|
5,193 | $553,677 |
All Filings in ALNY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,304,471 | 20,943 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $5,309,470 | 16,047 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $10,052,989 | 25,281 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $295,644,864 | 648,344 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $195,690,195 | 600,111 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $19,601,291 | 72,592 | Shares | Sole | 2025-08-14 | |
| 2024-12-31 | $14,274,845 | 60,664 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $19,971,578 | 72,616 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $14,447,565 | 59,455 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $8,355,300 | 55,907 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $8,999,523 | 47,017 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $8,129,952 | 45,906 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $8,551,857 | 45,024 | Shares | Sole | 2023-10-27 | |
| 2023-03-31 | $9,160,432 | 45,729 | Shares | Sole | 2023-06-01 | |
| 2022-12-31 | $10,746,057 | 45,218 | Shares | Sole | 2023-02-21 | |
| 2022-09-30 | $8,863,884 | 44,284 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $6,261,631 | 42,932 | Shares | Sole | 2022-08-17 | |
| 2022-03-31 | $7,055,923 | 43,211 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $7,311,440 | 43,115 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $10,118,894 | 53,593 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $9,085,084 | 53,593 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $7,552,675 | 53,493 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $5,627,050 | 43,295 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $6,426,346 | 44,137 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $8,108,577 | 54,747 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $6,128,581 | 56,303 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||